ReviewBiodesign research2025
Enzyme promiscuity in the field of synthetic biology applied to white biotechnology: Opportunities and weaknesses.
Review in Biodesign research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nature-Inspired Enzymatic Cascades: Emerging Strategies for Sustainable Chemistry.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
White biotechnology stands as a major sustainable alternative to address pressing environmental issues arising from our heavy dependence on petrochemical synthesis. However, reaching this goal, both technologically and economically, will take time, resources and money. A major reason is within the biological system itself, as it has evolved into a bow-tie structure in which carbon and energy are converted, via highly regulated, complex and interconnected metabolic networks, into cellular components for growth and homeostasis. This objective is fundamentally at odds with that of biotechnology, which aims to convert carbon and energy into bioproducts. Engineering of microorganism using systems and synthetic biological systems tools has been developed to provide a compromise between these two objectives. However, these genetic and metabolic interventions have revealed often unexpected physiological behaviors, in part due to the fact that a large proportion of metabolic enzymes are catalyzing other reactions than those for which they were evolved. While this promiscuity is the source of an underground metabolism that can prove very advantageous in building high-performance production routes, it is also responsible for loss of yield and production due to metabolic disturbances, negative cross-talks between natural and heterologous pathways as well as it is at the onset of metabolic damages. Identifying these promiscuous enzymes and thus anticipating their opportunities or weaknesses in engineering microbial cell factories for bioproduction is a major challenge in order to improve their performance. It is foreseen that machine learning tools operating on databases continuously fed by genetic, metabolic, enzymatic and fermentation processes data can help to overcome these challenges and provide a better understanding of the physiological functioning of the microbial system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.